Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000711377-24-000058
Filing Date
2024-11-05
Accepted
2024-11-05 13:07:26
Documents
1
Period of Report
2024-11-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5366
  Complete submission text file 0000711377-24-000058.txt   6747
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Issuer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Bernard Thierry (Reporting) CIK: 0001815490 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17988 | Film No.: 241426665